Ready to use the right loop for you?

Feel the freedom with Dexcom CGM

Dexcom’s real-time continuous glucose monitoring (CGM) systems communicate with the widest choice of insulin pumps†,‡,1 to automatically§ adjust your insulin levels – giving you the freedom and peace of mind to truly live life on your terms.

Zero finger pricks*

With a Dexcom CGM, you get real-time glucose readings with no painful finger pricks, and no scanning, ever. And when used as part of an hybrid closed loop (HCL) system, you will no longer need multiple daily insulin injections, too.

Proven outcomes

HCL systems powered by Dexcom are proven to significantly increase Time in Range2–4, giving you less of the highs and lows that can cause long and short-term complications2,5, improving sleep and lightening the burden of living with diabetes.2,6,7

Advanced protection

Dexcom has safely powered HCL systems for over 1 million patient-years of cumulative use.8 The in-built Urgent Low Soon Alert lets you know up to 20 minutes before you go low, and you can share data with up to 10 followers for added peace of mind.||,¶

Be better connected with Dexcom

With Dexcom you get the widest choice of connected insulin pumps†,‡,1, so you can be sure you’re using the best CGM and connected insulin pump for your diabetes needs.
t:slim X2 insulin Pump logo

Tandem diabetes care

The Tandem advanced Hybrid Closed Loop technology adjusts insulin delivery to help prevent highs and lows.9 Connects with Dexcom G6 and G7.
  • Learn more about Tandem
my life - YpsoPump logo

Mylife YpsoPump

The mylife YpsoPump insulin pump links with the mylife CamAPS FX app to form a hybrid closed loop system, powered by Dexcom G6. Also suitable for use in pregnancy.
Omnipod® 5 logo - autimated insulin delivery system

Omnipod® 5 Automated Insulin Delivery System

The first wearable, tubeless, hybrid closed loop insulin delivery system for people with Type 1 diabetes aged 2 years and older.
my life - Diabetescare logo

Mylife App + mylife YpsoPump

This keeps you in the driver’s seat: an app and insulin pump combo pulls CGM data and insulin dosing into one place for easy (but not automated) insulin management.
two girls sitting on the bench of a tennis field using a HCL system

Big news! NICE now recommends HCL systems for people with Type 1 diabetes#

The National Institute for Health and Care Excellence (NICE) already recommends that all people living with Type 1 diabetes (T1D) are offered a choice of glucose sensor, including Dexcom real-time continuous glucose monitoring (CGM) systems.§,2
HCL systems are now also recommended for anyone with T1D who is:§,3
  • Under 18 years old
  • Over 18 with an elevated HbA1c of 7.5 or above
  • Experiencing disabling hypoglycaemia
  • Women who are pregnant or planning a pregnancy
  • People already using an insulin pump

Ready to take the next step?

Already a Dexcom user?

Speak with your Healthcare Team about NHS funding and see what’s available to you.
  • Explore connected insulin pump options

Not yet on Dexcom?

Get set up with a Dexcom CGM and feel the difference for yourself.
* If your glucose alerts and readings from the Dexcom system do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† Dexcom G6 is the most connected CGM system available with over 60 connected partners worldwide. Not all Dexcom systems have the same connectivity. Please check connectivity opexcomat
dexcom.com/en-gb/integrations-and-connectivity.
‡ Insulin pumps by Tandem, Insulet and Ypsomed.
§ The need and extent of manual input varies by hybrid closed loop system.
|| Following requires an internet connection and the Dexcom Follow app. Internet connectivity required for data sharing.
¶ The Dexcom app including Urgent Low Soon Alert and Share and Follow functionality cannot be used with the MyLife App.
# Access to Dexcom real-time CGM systems can vary in different parts of the UK. Talk to your diabetes healthcare team to find out more about access and which product would work best for you.
1 Dexcom data on file, 2022.
2 Peacock S, et al. Diabetes Ther. 2023;14(5):839–55.
3 Brown SA, et al. N Engl J Med. 2019;381(18):1707–17.
4 Breton MD, et al. 2020;383(9):836–45.
5 Brown SA, et al. Diabetes Care. 2021;44(7):1630–40.
6 Sherr JL, et al. Diabetes Care. 2022;45(12):3058–74.
7 Farrington C. Diabet Med 2018;35:436–49.
8 Dexcom data on file, 2023.
9 Beck RW, et al. Diabetes Technol Ther. 2023;25(5):384–91.
10 Tauschmann M, et al. Lancet 2018;392(10155):1321–9.
11 National Institute for Health and Care Excellence
https://www.nice.org.uk/guidance/gid-ta10845/documents/final-appraisal-determinationdocument.

MAT-0729

© 2026 Dexcom, Inc. All rights reserved.

GB flag

GB

Change region